Biochemical progression rates in the screen arm compared to the control arm of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer (ERSPC)-Reference-Cited by-同舟云学术

Biochemical progression rates in the screen arm compared to the control arm of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer (ERSPC)

Published:2006-07-01 Issue:10 Volume:66 Page:1076-1081
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Roemeling Stijn,Roobol Monique J.,Gosselaar Claartje,Schröder Fritz H.

Publisher

Wiley

Subject

Urology,Oncology

Reference23 articles.

1. Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

2. Dutch Comprehensive Cancer Center. (http://www.ikcnet.nl).

3. US National Cancer Institute. (http://www.cancer.gov/).

4. Global Cancer Statistics, 2002

5. Large-scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors of prostate cancer mortality in a Finnish randomized screening trial;International Journal of Urology;2017-12-10

2. Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK;BJU International;2010-01

3. Reply to Rune Kvåle, Eivor Hernes and Freddie Bray's Letter to the Editor re: E. David Crawford, Per-Anders Abrahamsson. PSA-based Screening for Prostate Cancer: How Does It Compare with Other Cancer Screening Tests? Eur Urol 2008;54:262–73;European Urology;2009-05

4. PSA-based Screening for Prostate Cancer: How Does It Compare with Other Cancer Screening Tests?;European Urology;2008-08

5. Cancer de la prostate;Progrès en Urologie;2007-11